VOR vs. NKE
Compare and contrast key facts about Vor Biopharma Inc. (VOR) and NIKE, Inc. (NKE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VOR or NKE.
Key characteristics
| VOR | NKE | |
|---|---|---|
| YTD Return | -57.42% | -29.26% |
| 1Y Return | -48.49% | -27.98% |
| 3Y Return (Ann) | -61.83% | -23.24% |
| Sharpe Ratio | -0.57 | -0.87 |
| Sortino Ratio | -0.57 | -0.99 |
| Omega Ratio | 0.94 | 0.83 |
| Calmar Ratio | -0.49 | -0.50 |
| Martin Ratio | -0.98 | -1.14 |
| Ulcer Index | 49.57% | 25.96% |
| Daily Std Dev | 84.71% | 33.94% |
| Max Drawdown | -98.82% | -64.43% |
| Current Drawdown | -98.23% | -55.63% |
Fundamentals
| VOR | NKE | |
|---|---|---|
| Market Cap | $65.53M | $112.95B |
| EPS | -$1.73 | $3.49 |
| Total Revenue (TTM) | $12.23M | $50.01B |
| Gross Profit (TTM) | $9.49M | $22.42B |
| EBITDA (TTM) | -$86.75M | $6.86B |
Correlation
The correlation between VOR and NKE is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
VOR vs. NKE - Performance Comparison
In the year-to-date period, VOR achieves a -57.42% return, which is significantly lower than NKE's -29.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VOR vs. NKE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and NIKE, Inc. (NKE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
VOR vs. NKE - Dividend Comparison
VOR has not paid dividends to shareholders, while NKE's dividend yield for the trailing twelve months is around 1.95%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VOR Vor Biopharma Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NKE NIKE, Inc. | 1.95% | 1.28% | 1.07% | 0.68% | 0.71% | 0.89% | 1.11% | 1.18% | 1.30% | 0.93% | 1.04% | 1.11% |
Drawdowns
VOR vs. NKE - Drawdown Comparison
The maximum VOR drawdown since its inception was -98.82%, which is greater than NKE's maximum drawdown of -64.43%. Use the drawdown chart below to compare losses from any high point for VOR and NKE. For additional features, visit the drawdowns tool.
Volatility
VOR vs. NKE - Volatility Comparison
Vor Biopharma Inc. (VOR) has a higher volatility of 22.36% compared to NIKE, Inc. (NKE) at 6.07%. This indicates that VOR's price experiences larger fluctuations and is considered to be riskier than NKE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
VOR vs. NKE - Financials Comparison
This section allows you to compare key financial metrics between Vor Biopharma Inc. and NIKE, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities